Search results
Study Examines Merkel Cell Carcinoma in Non-White Hispanics
Medscape· 2 days agoThe findings underscore "the importance of considering race/ethnicity in understanding the...
Staying safe in the sun: tips to prevent skin cancer during summer
WCMH via Yahoo News· 3 hours agoCOLUMBUS, Ohio (WCMH) – With summer approaching, many will be going to swimming pools and staying...
..., in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous...
Morningstar· 2 days agoTAMPA, FL and SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome ...
Douglas Kevin Allaire
The Gazette· 13 hours agoDouglas Kevin Allaire Iowa City Douglas Kevin Allaire, 75, of Iowa City/Coralville, died Thursday, May 30, 2024 at The Birdhouse …
TuHURA reports breakthrough in cancer vaccine trial By Investing.com
Investing.com· 2 days ago(NASDAQ:KTRA), has announced positive results from a Phase 1b trial of its leading cancer vaccine...
4 of the most common head and neck skin cancers, and how to identify them
ClickOnDetroit· 4 days agoGetting a sun-kissed tan might look great, but it ultimately causes damage that can lead to skin...
Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 6 days agoThe newly approved medicine, Zynyz (retifanlimab-dlwr), generated sales of $0.46 million. The...
Athena Bitcoin Global Announces CFO Transition
Digital Journal· 2 days ago... from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoMerus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today ...
